AAPL343.01-0.90 (-0.26%) ▼|ABBV286.49-0.37 (-0.13%) ▼|ABT103.75-1.13 (-1.08%) ▼|ACN237.94-9.29 (-3.76%) ▼|ADBE251.84-6.78 (-2.62%) ▼|AMAT387.39-0.21 (-0.05%) ▼|AMD546.64+15.36 (+2.89%) ▲|AMGN445.45+0.82 (+0.18%) ▲|AMT187.21-1.08 (-0.57%) ▼|AMZN249.64+0.55 (+0.22%) ▲|AVGO337.32+8.15 (+2.48%) ▲|AXP313.64-1.41 (-0.45%) ▼|BA185.35-2.96 (-1.57%) ▼|BAC50.66+0.14 (+0.27%) ▲|BKNG151.00-2.14 (-1.40%) ▼|BLK1,131.08+3.42 (+0.30%) ▲|BMY61.33-0.28 (-0.45%) ▼|BNY147.54+0.36 (+0.24%) ▲|BRK-B544.92-3.64 (-0.66%) ▼|C122.83+1.79 (+1.48%) ▲|CAT703.11+10.98 (+1.59%) ▲|CL92.53-0.58 (-0.62%) ▼|CMCSA22.00-0.05 (-0.23%) ▼|COF202.51+0.16 (+0.08%) ▲|COP149.88-1.49 (-0.98%) ▼|COST997.30-7.86 (-0.78%) ▼|CRM242.68-4.93 (-1.99%) ▼|CSCO110.34+0.10 (+0.09%) ▲|CVS92.46-0.07 (-0.08%) ▼|CVX230.49-1.52 (-0.66%) ▼|DE650.76+9.51 (+1.48%) ▲|DHR231.87-1.10 (-0.47%) ▼|DIS109.83-0.57 (-0.52%) ▼|DUK124.33-0.11 (-0.09%) ▼|EMR163.10+1.40 (+0.87%) ▲|FDX304.14+3.56 (+1.18%) ▲|GD355.79-1.25 (-0.35%) ▼|GE293.40+4.97 (+1.72%) ▲|GEV874.06+19.44 (+2.27%) ▲|GILD157.38-1.31 (-0.83%) ▼|GM80.10+3.79 (+4.96%) ▲|GOOG314.70+0.51 (+0.16%) ▲|GOOGL318.22+1.42 (+0.45%) ▲|GS911.06+17.78 (+1.99%) ▲|HD317.96-1.43 (-0.45%) ▼|HON217.21-2.07 (-0.94%) ▼|IBM250.80-2.64 (-1.04%) ▼|INTC92.22+1.75 (+1.93%) ▲|INTU330.60-9.29 (-2.73%) ▼|ISRG449.42-2.21 (-0.49%) ▼|JNJ267.30+1.00 (+0.38%) ▲|JPM336.32+2.28 (+0.68%) ▲|KO92.66-0.04 (-0.04%) ▼|LIN507.34-0.22 (-0.04%) ▼|LLY1,286.81+7.67 (+0.60%) ▲|LMT631.64-3.56 (-0.56%) ▼|LOW196.11-2.12 (-1.07%) ▼|LRCX237.11-0.40 (-0.17%) ▼|MA607.87-5.63 (-0.92%) ▼|MCD248.95-1.88 (-0.75%) ▼|MDLZ62.44-0.53 (-0.84%) ▼|MDT94.11-0.68 (-0.72%) ▼|META621.64-8.92 (-1.41%) ▼|MMM172.09-0.70 (-0.41%) ▼|MO73.20-0.43 (-0.58%) ▼|MRK140.82+0.21 (+0.15%) ▲|MS186.22+2.73 (+1.49%) ▲|MSFT528.97-3.63 (-0.68%) ▼|MU914.58+10.88 (+1.20%) ▲|NEE82.20+0.16 (+0.20%) ▲|NFLX63.06-0.85 (-1.32%) ▼|NKE37.74-0.17 (-0.45%) ▼|NOW154.24-3.94 (-2.49%) ▼|NVDA215.85-0.15 (-0.07%) ▼|ORCL129.92+3.86 (+3.06%) ▲|PEP134.52-0.94 (-0.69%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG159.07-0.86 (-0.53%) ▼|PLTR197.40-1.44 (-0.72%) ▼|PM203.35+1.48 (+0.73%) ▲|QCOM179.64+0.04 (+0.02%) ▲|RTX196.97-0.52 (-0.26%) ▼|SBUX101.44-1.26 (-1.22%) ▼|SCHW89.59-0.14 (-0.16%) ▼|SO91.96-0.62 (-0.66%) ▼|SPG211.59-1.10 (-0.52%) ▼|T20.95+0.10 (+0.46%) ▲|TMO688.36+3.47 (+0.51%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA401.33+9.71 (+2.48%) ▲|TXN302.37+4.25 (+1.43%) ▲|UBER65.67-0.46 (-0.70%) ▼|UNH411.41+0.71 (+0.17%) ▲|UNP296.79-0.18 (-0.06%) ▼|UPS103.16+2.84 (+2.83%) ▲|USB59.23-0.48 (-0.80%) ▼|V399.42-4.74 (-1.17%) ▼|VZ43.27+0.17 (+0.39%) ▲|WFC82.30-0.36 (-0.43%) ▼|WMT119.23-1.06 (-0.88%) ▼|XOM182.01-2.53 (-1.37%) ▼|AAPL343.01-0.90 (-0.26%) ▼|ABBV286.49-0.37 (-0.13%) ▼|ABT103.75-1.13 (-1.08%) ▼|ACN237.94-9.29 (-3.76%) ▼|ADBE251.84-6.78 (-2.62%) ▼|AMAT387.39-0.21 (-0.05%) ▼|AMD546.64+15.36 (+2.89%) ▲|AMGN445.45+0.82 (+0.18%) ▲|AMT187.21-1.08 (-0.57%) ▼|AMZN249.64+0.55 (+0.22%) ▲|AVGO337.32+8.15 (+2.48%) ▲|AXP313.64-1.41 (-0.45%) ▼|BA185.35-2.96 (-1.57%) ▼|BAC50.66+0.14 (+0.27%) ▲|BKNG151.00-2.14 (-1.40%) ▼|BLK1,131.08+3.42 (+0.30%) ▲|BMY61.33-0.28 (-0.45%) ▼|BNY147.54+0.36 (+0.24%) ▲|BRK-B544.92-3.64 (-0.66%) ▼|C122.83+1.79 (+1.48%) ▲|CAT703.11+10.98 (+1.59%) ▲|CL92.53-0.58 (-0.62%) ▼|CMCSA22.00-0.05 (-0.23%) ▼|COF202.51+0.16 (+0.08%) ▲|COP149.88-1.49 (-0.98%) ▼|COST997.30-7.86 (-0.78%) ▼|CRM242.68-4.93 (-1.99%) ▼|CSCO110.34+0.10 (+0.09%) ▲|CVS92.46-0.07 (-0.08%) ▼|CVX230.49-1.52 (-0.66%) ▼|DE650.76+9.51 (+1.48%) ▲|DHR231.87-1.10 (-0.47%) ▼|DIS109.83-0.57 (-0.52%) ▼|DUK124.33-0.11 (-0.09%) ▼|EMR163.10+1.40 (+0.87%) ▲|FDX304.14+3.56 (+1.18%) ▲|GD355.79-1.25 (-0.35%) ▼|GE293.40+4.97 (+1.72%) ▲|GEV874.06+19.44 (+2.27%) ▲|GILD157.38-1.31 (-0.83%) ▼|GM80.10+3.79 (+4.96%) ▲|GOOG314.70+0.51 (+0.16%) ▲|GOOGL318.22+1.42 (+0.45%) ▲|GS911.06+17.78 (+1.99%) ▲|HD317.96-1.43 (-0.45%) ▼|HON217.21-2.07 (-0.94%) ▼|IBM250.80-2.64 (-1.04%) ▼|INTC92.22+1.75 (+1.93%) ▲|INTU330.60-9.29 (-2.73%) ▼|ISRG449.42-2.21 (-0.49%) ▼|JNJ267.30+1.00 (+0.38%) ▲|JPM336.32+2.28 (+0.68%) ▲|KO92.66-0.04 (-0.04%) ▼|LIN507.34-0.22 (-0.04%) ▼|LLY1,286.81+7.67 (+0.60%) ▲|LMT631.64-3.56 (-0.56%) ▼|LOW196.11-2.12 (-1.07%) ▼|LRCX237.11-0.40 (-0.17%) ▼|MA607.87-5.63 (-0.92%) ▼|MCD248.95-1.88 (-0.75%) ▼|MDLZ62.44-0.53 (-0.84%) ▼|MDT94.11-0.68 (-0.72%) ▼|META621.64-8.92 (-1.41%) ▼|MMM172.09-0.70 (-0.41%) ▼|MO73.20-0.43 (-0.58%) ▼|MRK140.82+0.21 (+0.15%) ▲|MS186.22+2.73 (+1.49%) ▲|MSFT528.97-3.63 (-0.68%) ▼|MU914.58+10.88 (+1.20%) ▲|NEE82.20+0.16 (+0.20%) ▲|NFLX63.06-0.85 (-1.32%) ▼|NKE37.74-0.17 (-0.45%) ▼|NOW154.24-3.94 (-2.49%) ▼|NVDA215.85-0.15 (-0.07%) ▼|ORCL129.92+3.86 (+3.06%) ▲|PEP134.52-0.94 (-0.69%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG159.07-0.86 (-0.53%) ▼|PLTR197.40-1.44 (-0.72%) ▼|PM203.35+1.48 (+0.73%) ▲|QCOM179.64+0.04 (+0.02%) ▲|RTX196.97-0.52 (-0.26%) ▼|SBUX101.44-1.26 (-1.22%) ▼|SCHW89.59-0.14 (-0.16%) ▼|SO91.96-0.62 (-0.66%) ▼|SPG211.59-1.10 (-0.52%) ▼|T20.95+0.10 (+0.46%) ▲|TMO688.36+3.47 (+0.51%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA401.33+9.71 (+2.48%) ▲|TXN302.37+4.25 (+1.43%) ▲|UBER65.67-0.46 (-0.70%) ▼|UNH411.41+0.71 (+0.17%) ▲|UNP296.79-0.18 (-0.06%) ▼|UPS103.16+2.84 (+2.83%) ▲|USB59.23-0.48 (-0.80%) ▼|V399.42-4.74 (-1.17%) ▼|VZ43.27+0.17 (+0.39%) ▲|WFC82.30-0.36 (-0.43%) ▼|WMT119.23-1.06 (-0.88%) ▼|XOM182.01-2.53 (-1.37%) ▼|
12.3 C
New York
Tuesday, October 27, 2026

Tag: pharmaceutical

Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies

ABU DHABI, UAE, Oct. 18, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the...

Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies

ABU DHABI, UAE, Oct. 17, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the...

FPT Communiqué – Federal, Provincial and Territorial (FPT) Health Ministers’ Meeting

WINNIPEG, MB, Oct. 16, 2026 /CNW/ -- Today, Canada's Federal, Provincial and Territorial (FPT) Ministers of Health and Ministers of Mental Health, Addictions, and...

Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia

PITTSBURGH, Oct. 16, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has...

Myosin Therapeutics Invited to Present at BioFuture 2026 in New York City

JUPITER, Fla., Oct. 16, 2026 /PRNewswire/ -- Myosin Therapeutics today announced that, following its selection as a 2026–2027 National Cancer Institute (NCI) SBIR Investor Initiatives...

CRISPR Market worth $6.12 billion by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 16, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the CRISPR Market is projected to reach USD 6.12 billion by 2031 from USD...

Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development

– Brings more than 20 years of oncology business development and commercial leadership, including senior roles across the radiopharmaceutical sector at Bayer, Clovis Oncology,...

65 Vietnamese Leaders and Enterprises Honored at Asia Pacific Enterprise Awards 2026 for Forging Legacies of Excellence

HO CHI MINH CITY, Vietnam, Oct. 16, 2026 /PRNewswire/ -- 65 distinguished leaders and enterprises were honored for their outstanding achievements, entrepreneurial spirit, and...

Perceptive Discovery Launches Astatine-211 Study Capabilities in the US and UK

Perceptive Discovery becomes the first US provider able to support At-211 studies, expanding access to specialized radiopharmaceutical development infrastructure through its collaboration with Atley...

Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates

NEW TAIPEI CITY, Oct. 16, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to...

XtalPi Nominates Its First siRNA Preclinical Candidate for IgA Nephropathy Nine Months After Program Initiation

Preclinical data demonstrate subnanomolar silencing potency, achieving an IC50 tens of times lower than the corresponding values for two clinical-stage reference molecules targeting the...

MAHA PAC and MAHA Action PAC announce Make Iowa Healthy Again Rally & Commits over $1.9 Million to Elect Zach Lahn and support Six...

MAHA Action PAC donates $1.5 million to Zach Lahn's campaign for governor of Iowa, is deploying MAHA volunteers for a 15-day field program across...

Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs,...

The neuroendocrine prostate cancer market is expected to grow steadily, driven by the rising recognition of NEPC as an aggressive and treatment-resistant form of...

Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs,...

The neuroendocrine prostate cancer market is expected to grow steadily, driven by the rising recognition of NEPC as an aggressive and treatment-resistant form of...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPharmaceutical